Anacor Pharma (ANAC) Misses Q4 EPS by 13c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CRWD
5. CHKP
6. ON
7. HNGE
8. INSP
9. MTCH
10. CVI

Go back to Anacor Pharma (ANAC) Misses Q4 EPS by 13c

Jefferies Cuts Price Target on Anacor Pharma (ANAC) to $105 Following a 4Q EPS Miss

March 1, 2016 9:12 AM EST

Jefferies maintained a Buy rating on Anacor Pharmaceuticals (NASDAQ: ANAC), and cut the price target to $105.00 (from $159.00), following the company's 4Q earnings report. ANAC reported an EPS loss of $0.43, missing Jefferies' estimates for a loss of $0.31. Management attributed the miss to short term competitive... More